TD Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Sell
162,976
-4,485
-3% -$299K 0.01% 633
2026
Q1
$10.5M Sell
167,461
-169,908
-50% -$11.8M 0.01% 633
2025
Q4
$22.4M Buy
337,369
+16,571
+5% +$1.07M 0.02% 491
2025
Q3
$21.6M Buy
320,798
+44,770
+16% +$3.54M 0.02% 490
2025
Q2
$24.1M Buy
276,028
+55,644
+25% +$4.36M 0.02% 461
2025
Q1
$15.1M Sell
220,384
-30,537
-12% -$2.49M 0.01% 551
2024
Q4
$19.5M Buy
250,921
+20,241
+9% +$1.5M 0.02% 513
2024
Q3
$15.5M Sell
230,680
-46,268
-17% -$3.8M 0.01% 554
2024
Q2
$31.4M Sell
276,948
-6,096
-2% -$771K 0.03% 370
2024
Q1
$39.3M Sell
283,044
-14,875
-5% -$1.87M 0.04% 342
2023
Q4
$37M Buy
297,919
+20,757
+7% +$2.12M 0.04% 343
2023
Q3
$25.9M Buy
277,162
+47,876
+21% +$5.4M 0.03% 383
2023
Q2
$29.5M Sell
229,286
-17,645
-7% -$2.13M 0.03% 363
2023
Q1
$28.7M Buy
246,931
+1,241
+0.5% +$139K 0.03% 358
2022
Q4
$27.8M Buy
245,690
+3,453
+1% +$379K 0.03% 370
2022
Q3
$19.9M Sell
242,237
-229
-0.1% -$19.4K 0.02% 415
2022
Q2
$18.1M Sell
242,466
-2,002
-0.8% -$183K 0.02% 454
2022
Q1
$31.3M Sell
244,468
-392
-0.2% -$42.9K 0.03% 386
2021
Q4
$32.9M Sell
244,860
-7,984
-3% -$1.15M 0.03% 396
2021
Q3
$34.6M Sell
252,844
-3,584
-1% -$452K 0.04% 358
2021
Q2
$33M Buy
256,428
+2,156
+0.8% +$207K 0.03% 371
2021
Q1
$22.8M Sell
254,272
-21,780
-8% -$2.04M 0.03% 435
2020
Q4
$25.5M Buy
276,052
+18,500
+7% +$1.65M 0.03% 386
2020
Q3
$26.5M Buy
257,552
+43,964
+21% +$4.59M 0.04% 332
2020
Q2
$21.6M Buy
213,588
+73,476
+52% +$6.57M 0.03% 344
2020
Q1
$9.43M Sell
140,112
-18,800
-12% -$1.17M 0.02% 485
2019
Q4
$8.69M Sell
158,912
-18,168
-10% -$862K 0.01% 585
2019
Q3
$6.61M Buy
177,080
+7,000
+4% +$272K 0.01% 623
2019
Q2
$6.37M Buy
170,080
+61,776
+57% +$1.94M 0.01% 632
2019
Q1
$3.23M Buy
108,304
+58,436
+117% +$2.05M ﹤0.01% 801
2018
Q4
$1.49M Sell
49,868
-235,224
-83% -$7.46M ﹤0.01% 982
2018
Q3
$10.2M Sell
285,092
-32,800
-10% -$1.02M 0.02% 532
2018
Q2
$7.55M Sell
317,892
-139,364
-30% -$2.95M 0.01% 585
2018
Q1
$8.48M Buy
457,256
+11,600
+3% +$172K 0.01% 556
2017
Q4
$6.39M Buy
445,656
+300,640
+207% +$3.91M 0.01% 618
2017
Q3
$1.77M Buy
145,016
+40,168
+38% +$710K ﹤0.01% 898
2017
Q2
$1.92M Sell
104,848
-63,636
-38% -$1.18M ﹤0.01% 885
2017
Q1
$3.57M Sell
168,484
-35,116
-17% -$685K 0.01% 773
2016
Q4
$3.04M Buy
203,600
+150,800
+286% +$2.67M 0.01% 775
2016
Q3
$1.16M Sell
52,800
-19,200
-27% -$427K ﹤0.01% 979
2016
Q2
$1.43M Sell
72,000
-800
-1% -$13.6K ﹤0.01% 907
2016
Q1
$1.24M Sell
72,800
-1,200
-2% -$20K ﹤0.01% 928
2015
Q4
$1.51M Sell
74,000
-24,800
-25% -$516K ﹤0.01% 876
2015
Q3
$2.12M Sell
98,800
-10,000
-9% -$223K ﹤0.01% 804
2015
Q2
$2.17M Sell
108,800
-400
-0.4% -$7.03K ﹤0.01% 842
2015
Q1
$1.7M Buy
109,200
+9,200
+9% +$139K ﹤0.01% 855
2014
Q4
$1.38M Buy
100,000
+6,000
+6% +$73.5K ﹤0.01% 886
2014
Q3
$940K Buy
94,000
+10,400
+12% +$106K ﹤0.01% 911
2014
Q2
$829K Buy
83,600
+36,800
+79% +$326K ﹤0.01% 928
2014
Q1
$484K Buy
+46,800
New +$484K ﹤0.01% 1047

Other funds holding DXCM

TD Asset Management's DXCM Position: Q2 2026 in Review

TD Asset Management reduced its DexCom (DXCM) stake by 2.7% in Q2 2026, selling an estimated $299K and leaving 162,976 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #633.

TD Asset Management first reported a position in DXCM in Q1 2014 and has held it in 50 quarters since. The position peaked at $39.3M in Q1 2024. 764 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • TD Asset Management held 162,976 shares of DexCom worth $11M as of Q2 2026.
  • TD Asset Management sold 4,485 DexCom shares in Q2 2026, an estimated $299K.
  • DexCom made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #633 holding.
  • TD Asset Management first reported a position in DexCom in Q1 2014 and has held it in 50 quarters since.
  • TD Asset Management's DexCom position peaked at $39.3M in Q1 2024.
  • 764 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.